CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
Jung Hoon Lee, Tae Nyeun Kim, Sun Taek Choi, Byung Ik Jang, Kyeong-Cheol Shin, Sam Beom Lee, Young Ran Shim
Korean J Intern Med. 2007;22(1):24-27.   Published online 2007 March 31    DOI: https://doi.org/10.3904/kjim.2007.22.1.24

Excel Download

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
The Korean Journal of Internal Medicine. 2007;22(1):24   Crossref logo
Link1 Link2 Link3

Long-Term Partial Remission of AutoImmune Thrombocytopenia in a Patient Treated with the Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab for Refractory Fistulizing Crohn’s Disease
Digestion. 2008;78(4):195-200   Crossref logo
Link1 Link2

ANTI-TUMOR NECROSIS FACTOR-α MONOCLONAL ANTIBODY THERAPY FOR RHEUMATOID ARTHRITIS
Rheumatic Disease Clinics of North America. 1998;24(3):593-614   Crossref logo
Link1 Link2

Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report
Gastroenterology. 2001;120(4):995-999   Crossref logo
Link1 Link2

The effect of monoclonal anti-tumor necrosis factor-antibody cA2 on coagulation- and fibrinolytic parameters in patients with active Crohn's disease
Gastroenterology. 1995;108(4):A838   Crossref logo
Link1 Link2

Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-a Monoclonal Antibody Treatment for Crohn's Disease
Digestion. 2013;88(1):17-19   Crossref logo
Link1 Link2

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
Gastroenterology. 1999;117(4):761-769   Crossref logo
Link1 Link2

A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease
Gastroenterology. 1997;113(3):1042-1043   Crossref logo
Link1 Link2

Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
BMC Musculoskeletal Disorders. 2003;4(1):   Crossref logo
Link1 Link2 Link3

Monoclonal Anti-Tumor Necrosis Factor-Alpha Antibody for the Treatment of Severe Acute Graft-versus-Host Disease
Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance. ;102-106   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.